John D. Quisel - 29 Dec 2022 Form 4 Insider Report for Disc Medicine, Inc. (IRON)

Reporting relationship: Chief Executive Officer, Director
Issuer ticker: IRON
Reported as of: 29 Dec 2022
Net transaction value: $0
SEC form: 4
Accepted by SEC: 03 Jan 2023, 16:05:30 UTC
Next SEC filing: 29 Nov 2023
Source filing: View source filing
Reporting owner signature: By: /s/ Rahul Khara, as Attorney-in-Fact

Key filing fact

John D. Quisel filed Form 4 for Disc Medicine, Inc. (IRON) on 03 Jan 2023.

Key facts

This page summarizes John D. Quisel's Form 4 filing for Disc Medicine, Inc. (IRON).
1 reported transaction and 1 derivative row are listed below.
Accepted by SEC: 03 Jan 2023, 16:05.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

IRON transaction Derivative

Stock Option (Right to Buy)

Award

Transaction value: $0
Shares: +132,002
Change %
Price: $0.000000
Shares after: 132,002
Date: 29 Dec 2022
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 132,002
Exercise price: $13.50
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

The shares underlying this option vest in 48 equal monthly installments following December 29, 2022, subject to the Reporting Person's continued service on each such vesting date.